Skip to main content
logo
Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
10.69
+0.14 (1.33%)
At close: Oct 19, 2026, 4:00 PM EDT
10.69
0.00 (0.00%)
After-hours: Oct 19, 2026, 4:00 PM EDT

Helus Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
78124013331476142
Market Cap Growth
399.93%80.08%-57.57%314.56%-46.50%-13.35%
Enterprise Value
61545392855991
Last Close Price
10.554.806.3415.7114.6331.05

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PB Ratio
2.701.040.811.462.132.32
P/TBV Ratio
4.361.451.332.045.713.46

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
---0.00--
Net Debt / Equity Ratio
-0.69-0.68-0.57-0.71-0.34-0.70
Net Debt / EBITDA Ratio
1.001.100.912.660.320.84
Net Debt / FCF Ratio
1.181.181.303.030.351.18
Quick Ratio
9.768.386.5821.143.487.05
Current Ratio
10.979.527.7521.654.097.38
Return on Equity (ROE)
-86.94%-74.60%-44.34%-45.91%-76.36%-83.35%
Return on Assets (ROA)
-44.38%-41.35%-33.05%-27.69%-46.68%-45.29%
Return on Capital Employed (ROCE)
-69.00%-61.50%-62.50%-27.00%-106.80%-83.80%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-22.42%-61.62%-61.19%-18.34%-46.29%-38.22%
FCF Yield
-18.44%-55.57%-54.25%-16.19%-46.37%-25.61%
Buyback Yield / Dilution
-103.06%-72.10%-143.72%-70.01%-10.85%-67.27%
SEC Filings: 10-K · 10-Q